Cause-Specific Mortality among Patients in Treatment for Opioid Use Disorder in Multiple Settings: A Prospective Comparative Cohort Study

Introduction: Among people receiving current or previous opioid maintenance treatment (OMT), the leading cause of premature death is an opioid overdose. However, other causes of mortality remain high in this group. An understanding of causes of deaths across multiple settings can be useful in informing more comprehensive prevention responses. The aim of this study was to describe all non-overdose causes of death in three national cohorts (Czechia, Denmark, and Norway) among OMT patients and to explore associations of non-overdose mortality with age and gender. Methods: This prospective comparative cohort study used national mortality registry databases for OMT patients from Czechia (2000–2019), Denmark (2000–2018), and Norway (2010–2019). Crude mortality rates and age-standardized mortality rates (ASMRs) were calculated as deaths per 1,000 person years for cause-specific mortality. Results: In total, 29,486 patients were included, with 5,322 deaths recorded (18%). We found variations in causes of death among the cohorts and within gender and age groups. The leading non-overdose causes of death were accidents in Czechia and Denmark, and neoplasms in Norway. Cardiovascular deaths were highest in Czechia, particularly for women in OMT (ASMR 3.59 vs. 1.24 in Norway and 1.87 in Denmark). Conclusion: This study found high rates of preventable death among both genders and all age groups. Different demographic structures, variations in risk exposure, as well as variations in coding practices can explain the differences. The findings support increased efforts towards screening and preventative health initiatives among OMT patients specific to the demographic characteristics in different settings.

[1]  J. Marrugat,et al.  High cardiovascular risk in older patients with opioid use disorder: Differences with the general population. , 2022, Drug and alcohol review.

[2]  L. Degenhardt,et al.  Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis. , 2021, JAMA psychiatry.

[3]  T. Clausen,et al.  Opioid maintenance treatment in the Czech Republic, Norway and Denmark: a study protocol of a comparative registry linkage study , 2021, BMJ Open.

[4]  T. Babor,et al.  The identification of artefacts in reporting of drug-induced deaths using structural breaks analysis of time series statistics. , 2021, Drug and alcohol review.

[5]  L. Ación,et al.  Late- and Typical-Onset Heroin Use Among Older Adults Seeking Treatment for Opioid Use Disorder. , 2020, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[6]  T. Clausen,et al.  Large and non-specific somatic disease burdens among ageing, long-term opioid maintenance treatment patients , 2020, Substance Abuse Treatment, Prevention, and Policy.

[7]  J. Skogen,et al.  Suicide among people treated for drug use disorders: a Danish national record-linkage study , 2019, BMC Public Health.

[8]  Hong-xian Chen,et al.  Prevalence and correlates of suicide attempt among Chinese individuals receiving methadone maintenance treatment for heroin dependence , 2019, Scientific Reports.

[9]  A. Bukten,et al.  From restrictive to more liberal: variations in moratlity among patients in opioid maintenance treament over a 12-year period , 2019, BMC Health Services Research.

[10]  J. Šaltytė Benth,et al.  Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study , 2019, BMC Health Services Research.

[11]  S. Bird,et al.  Non drug-related and opioid-specific causes of 3262 deaths in Scotland’s methadone-prescription clients, 2009–2015 , 2019, Drug and alcohol dependence.

[12]  Eric C Strain,et al.  A hidden aspect of the U.S. opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder. , 2018, Drug and alcohol dependence.

[13]  S. Tabaei,et al.  Cardiovascular complications and related risk factors underlying opium consumption , 2018, Journal of cellular physiology.

[14]  C. Comiskey,et al.  Rising incidence of ageing opioid users within the EU wide treatment demand indicator; The Irish opioid epidemic from 1996 to 2014. , 2018, Drug and alcohol dependence.

[15]  J. Leung,et al.  Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs , 2018, Addiction.

[16]  H. Larsson,et al.  Medications for Alcohol and Opioid Use Disorders and Risk of Suicidal Behavior, Accidental Overdoses, and Crime. , 2018, The American journal of psychiatry.

[17]  S. Bird,et al.  Ageing opioid users’ increased risk of methadone-specific death in the UK , 2018, The International journal on drug policy.

[18]  H. Hagan,et al.  Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis , 2017, Addiction.

[19]  Lu Gao,et al.  Risk-factors for methadone-specific deaths in Scotland’s methadone-prescription clients between 2009 and 2013* , 2016, Drug and alcohol dependence.

[20]  T. Clausen,et al.  Methadone-Related Overdose Deaths in a Liberal Opioid Maintenance Treatment Programme , 2016, European Addiction Research.

[21]  K. Delucchi,et al.  An international systematic review of smoking prevalence in addiction treatment. , 2016, Addiction.

[22]  S. Ross,et al.  Demographic Trends of Adults in New York City Opioid Treatment Programs—An Aging Population , 2015, Substance use & misuse.

[23]  T. Clausen,et al.  Cardiovascular disease among people with drug use disorders , 2015, International Journal of Public Health.

[24]  J. Amin,et al.  Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: a 15-year observational cohort study. , 2015, Drug and alcohol dependence.

[25]  Matt Anderson,et al.  European Monitoring Centre for Drugs and Drug Addiction , 2014 .

[26]  Michael Soyka,et al.  Alcohol Use Disorders in Opioid Maintenance Therapy: Prevalence, Clinical Correlates and Treatment , 2014, European Addiction Research.

[27]  M. Bulsara,et al.  Multimorbidity in patients enrolled in a community-based methadone maintenance treatment programme delivered through primary care , 2014, Journal of comorbidity.

[28]  D. Blazer,et al.  Substance use disorders and psychiatric comorbidity in mid and later life: a review. , 2014, International journal of epidemiology.

[29]  J. Kyselý,et al.  Comparison of UTCI with Other Thermal Indices in the Assessment of Heat and Cold Effects on Cardiovascular Mortality in the Czech Republic , 2014, International journal of environmental research and public health.

[30]  N. Sarrafzadegan,et al.  Effects of opium consumption on cardiometabolic diseases , 2013, Nature Reviews Cardiology.

[31]  A. Anis,et al.  Changes in the Characteristics and Levels of Comorbidity Among New Patients Into Methadone Maintenance Treatment Program in British Columbia During Its Expansion Period From 1998–2006 , 2013, Substance use & misuse.

[32]  Per Stangeland,et al.  Reductions in convictions for violent crime during opioid maintenance treatment: a longitudinal national cohort study. , 2012, Drug and alcohol dependence.

[33]  Per Stangeland,et al.  Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study. , 2012, Addiction.

[34]  K. Helweg-larsen.  The Danish Register of Causes of Death , 2011, Scandinavian journal of public health.

[35]  M. Law,et al.  Increasing cancer mortality among opioid‐dependent persons in Australia: a new public health challenge for a disadvantaged population , 2011, Australian and New Zealand Journal of Public Health.

[36]  R. Walker,et al.  Suicide and unintentional poisoning mortality trends in the United States, 1987-2006: two unrelated phenomena? , 2010, BMC public health.

[37]  M. Ilgen,et al.  Unintentional overdose and suicide among substance users: a review of overlap and risk factors. , 2010, Drug and alcohol dependence.

[38]  W. Hall,et al.  Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. , 2009, Drug and alcohol dependence.

[39]  T. Clausen,et al.  Mortality among opiate users: opioid maintenance therapy, age and causes of death. , 2009, Addiction.

[40]  T. Clausen,et al.  Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. , 2008, Drug and alcohol dependence.

[41]  R. Moos,et al.  Substance misuse among older adults: a neglected but treatable problem. , 2008, Addiction.

[42]  T. Rhodes,et al.  Global estimates of prevalence of HCV infection among injecting drug users. , 2007, The International journal on drug policy.

[43]  H. Waal.  Merits and Problems in High-Threshold Methadone Maintenance Treatment , 2007, European Addiction Research.

[44]  R. Brooner,et al.  Characteristics of older opioid maintenance patients. , 2005, Journal of substance abuse treatment.

[45]  S. Darke,et al.  Suicide among heroin users: rates, risk factors and methods. , 2002, Addiction.

[46]  C. Comiskey,et al.  Treatment for opioid use and outcomes in older adults: a systematic literature review. , 2018, Drug and alcohol dependence.

[47]  W. Hall,et al.  Causes of death in a cohort treated for opioid dependence between 1985 and 2005. , 2014, Addiction.

[48]  L. Degenhardt,et al.  Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. , 2011, Addiction.

[49]  K. Furu.  Establishment of the nationwide Norwegian Prescription Database (NorPD) – new opportunities for research in pharmacoepidemiology in Norway , 2008 .